Skip to content
Independent analysis of NHS open data
PharmaInsight

Powder discontinued extensively hydrolysed formula (0913351)

Nutrition and Blood Oral nutrition BNF 0913351A0
Data updated March 2026 Download CSV

Powder discontinued extensively hydrolysed formula (0913351) was dispensed in England in March 2026, with 1 items, little changed on a year earlier.

1items 0%

Dispensed in March 2026

3items

Rolling 12 months

£52

Net ingredient cost · March 2026

Figure 1. Powder discontinued extensively hydrolysed formula (0913351): national items dispensed by month

0 1.5 3 Feb 2023 Jun 2023 Nov 2023 Apr 2024 Oct 2024 Mar 2026 1 Feb 2023: 3 Mar 2023: 1 Apr 2023: 1 May 2023: 1 Jun 2023: 2 Jul 2023: 1 Aug 2023: 1 Oct 2023: 1 Nov 2023: 1 Dec 2023: 2 Jan 2024: 1 Mar 2024: 2 Apr 2024: 2 May 2024: 2 Jul 2024: 2 Aug 2024: 1 Oct 2024: 1 Nov 2024: 1 Mar 2025: 1 May 2025: 2 Aug 2025: 1 Dec 2025: 1 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Oral nutrition
  • Presentations 1 shown
  • Average cost / item £51.80
  • Year on year Little changed on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, March 2026

The individual products dispensed under Powder discontinued extensively hydrolysed formula (0913351) this month.

Presentations of Powder discontinued extensively hydrolysed formula (0913351), March 2026
Presentation BNF code Items Net ingredient cost
Nutramigen 1 LIPIL powder 0913351A0BBAAAA 1 £52

Source: NHSBSA Prescription Cost Analysis · to March 2026 OGL v3.0

Where Powder discontinued extensively hydrolysed formula (0913351) is dispensed

The regions and dispensing practices with the highest Powder discontinued extensively hydrolysed formula (0913351) volumes.

Top regions

Top dispensing practices

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Powder discontinued extensively hydrolysed formula (0913351) with

Other medicines in the same BNF section, by prescribing volume.